Literature DB >> 3571436

Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC).

C E Sigal, F H Valone, M J Holtzman, E J Goetzl.   

Abstract

The chemotactic responses of human blood neutrophils and of eosinophils of two different densities, which were resolved by centrifugation on gradients of polyvinylpyrrolidone-coated silica gel (Percoll), were quantified in modified Boyden micropore filter chambers using highly purified synthetic 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC or PAFacether) and leukotriene B4 (LTB4) as stimuli. Maximal chemotactic responses of the densest eosinophils, less dense eosinophils, and neutrophils were evoked by 1 nM, 100 nM, and 1 microM PAFacether, respectively, and by 30-100, 30-100, and 10 nM LTB4. The magnitude of the maximal chemotactic response to PAFacether of the densest eosinophils was significantly greater than that of neutrophils. The eosinophil responses to PAFacether were chemotactic, as distinguished from chemokinetic, and were not influenced by the percentage of contaminating neutrophils. PAFacether is a more potent chemotactic factor for eosinophils than neutrophils and selectively attracts the densest population of human blood eosinophils.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3571436     DOI: 10.1007/bf00916012

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  18 in total

1.  Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis.

Authors:  H Darius; D J Lefer; J B Smith; A M Lefer
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

2.  Separation of human eosinophils in density gradients of polyvinylpyrrolidone-coated silica gel (Percoll).

Authors:  I Gärtner
Journal:  Immunology       Date:  1980-05       Impact factor: 7.397

3.  Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.

Authors:  L M McManus; D J Hanahan; C A Demopoulos; R N Pinckard
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

4.  Novel effects of 1-O-hexadecyl-2-acyl-sn-glycero-3-phosphorycholine mediators on human leukocyte function: delineation of the specific roles of the acyl substituents.

Authors:  E J Goetzl; C K Derian; A I Tauber; F H Valone
Journal:  Biochem Biophys Res Commun       Date:  1980-06-16       Impact factor: 3.575

5.  Selective desensitization of neutrophils: further studies with 1-O-alkyl-sn-glycero-3-phosphocholine analogues.

Authors:  J T O'Flaherty; C J Lees; C H Miller; C E McCall; J C Lewis; S H Love; R L Wykle
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

6.  Human eosinophils and parasitic diseases. II. Characterization of two cell fractions isolated at different densities.

Authors:  C De Simone; G Donneli; D Meli; F Rosati; F Sorice
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

7.  Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC).

Authors:  F H Valone; E J Goetzl
Journal:  Am J Pathol       Date:  1983-10       Impact factor: 4.307

8.  Altered density, metabolism and surface receptors of eosinophils in eosinophilia.

Authors:  I Winqvist; T Olofsson; I Olsson; A M Persson; T Hallberg
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

9.  Rapid method for isolation of normal human peripheral blood eosinophils on discontinuous Percoll gradients and comparison with neutrophils.

Authors:  R L Roberts; J I Gallin
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

10.  Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).

Authors:  J O Shaw; R N Pinckard; K S Ferrigni; L M McManus; D J Hanahan
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

View more
  12 in total

Review 1.  The role of eosinophils in asthma.

Authors:  C Kroegel
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls.

Authors:  A Altomare; J Ma; M P L Guarino; L Cheng; F Rieder; M Ribolsi; C Fiocchi; P Biancani; K Harnett; M Cicala
Journal:  Neurogastroenterol Motil       Date:  2012-06-26       Impact factor: 3.598

3.  Effect of platelet activating factor (PAF) on the migration of human lymphocytes.

Authors:  R G McFadden; M A Bishop; A N Caveney; L J Fraher
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

4.  Platelet-activating factor receptor mRNA is localized in eosinophils and epithelial cells in rat small intestine: regulation by dexamethasone and gut flora.

Authors:  H Wang; X Tan; H Chang; W Huang; F Gonzalez-Crussi; W Hsueh
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

5.  Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced ligand vascular cell adhesion molecule-1 via the very late activation antigen-4 integrin receptor.

Authors:  A Dobrina; R Menegazzi; T M Carlos; E Nardon; R Cramer; T Zacchi; J M Harlan; P Patriarca
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

6.  Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils.

Authors:  P Kernen; M P Wymann; V von Tscharner; D A Deranleau; P C Tai; C J Spry; C A Dahinden; M Baggiolini
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

7.  Signaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells.

Authors:  Jie Ma; Karen M Harnett; Jose Behar; Piero Biancani; Weibiao Cao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-12-03       Impact factor: 4.052

8.  Viewpoints on Acid-induced inflammatory mediators in esophageal mucosa.

Authors:  Karen M Harnett; Florian Rieder; Jose Behar; Piero Biancani
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

Review 9.  Leukotriene B4 and platelet-activating factor in human skin.

Authors:  L Michel; L Dubertret
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

10.  Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics.

Authors:  C Kroegel; H Matthys
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.